Related references
Note: Only part of the references are listed.Excellent Tolerability But Relatively Low Initial Clinical Efficacy of Telcagepant in Migraine
Peer Tfelt-Hansen
HEADACHE (2011)
Unpublished clinical trials with sumatriptan
Peer Carsten Tfelt-Hansen
LANCET (2009)
Randomized, controlled trial of telcagepant for the acute treatment of migraine
K. M. Connor et al.
NEUROLOGY (2009)
Evaluation and registration of adverse events in clinical drug trials in migraine
P. Tfelt-Hansen et al.
CEPHALALGIA (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Pharmacokinetic and pharmacodynamic variability as possible causes for different drug responses in migraine. A comment
P. Tfelt-Hansen et al.
CEPHALALGIA (2007)
Marketed oral triptans in the acute treatment of migraine:: A systematic review on efficacy and tolerability
Julio Pascual et al.
HEADACHE (2007)
Treatment-emergent CNS symptoms following triptan therapy are part of the attack
P. J. Goadsby et al.
CEPHALALGIA (2007)
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers
KA Petersen et al.
CEPHALALGIA (2005)
Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: A multicenter, double-blind, placebo-controlled study conducted in the united states
F Sheftell et al.
HEADACHE (2003)
New directions in migraine research
PJ Goadsby
JOURNAL OF CLINICAL NEUROSCIENCE (2002)
Dose range-finding studies with frovatriptan in the acute treatment of migraine
A Rapoport et al.
HEADACHE (2002)
Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine:: results of a phase III, multicentre, placebo-controlled study across three attacks
R Stark et al.
CEPHALALGIA (2002)
Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine
C Dahlöf et al.
NEUROLOGY (2001)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:: a meta-analysis of 53 trials
MD Ferrari et al.
LANCET (2001)
Efficacy of naratriptan tablets in the acute treatment of migraine:: A dose-ranging study
H Havanka et al.
CLINICAL THERAPEUTICS (2000)
Share Paper
